Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa.

Sweeney S, Vassall A, Guinness L, Siapka M, Chimbindi N, Mudzengi D, Gomez GB.

Pharmacoeconomics. 2020 Apr 1. doi: 10.1007/s40273-020-00898-3. [Epub ahead of print]

PMID:
32239479
2.

The potential deployment of a pan-tuberculosis drug regimen in India: A modelling analysis.

Arinaminpathy N, Gomez GB, Sachdeva KS, Rao R, Parmar M, Nair SA, Rade K, Kumta S, Hermann D, Hanson C, Chin DP, Dewan P.

PLoS One. 2020 Mar 27;15(3):e0230808. doi: 10.1371/journal.pone.0230808. eCollection 2020.

3.

Evaluating the sustainability of differentiated service delivery interventions for stable ART clients in sub-Saharan Africa: a systematic review protocol.

Okere NE, Urlings L, Naniche D, de Wit TFR, Gomez GB, Hermans S.

BMJ Open. 2020 Feb 2;10(1):e033156. doi: 10.1136/bmjopen-2019-033156.

4.

The impact of self-selection based on HIV risk on the cost-effectiveness of pre-exposure prophylaxis in South Africa.

Jamieson L, Gomez GB, Rebe K, Brown B, Subedar H, Jenkins S, Shoko N, Bekker LG, Johnson LF, Meyer-Rath G.

AIDS. 2020 Jan 30. doi: 10.1097/QAD.0000000000002486. [Epub ahead of print]

PMID:
32004205
5.

Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: methodology and lessons learned.

DeCormier Plosky W, Bollinger LA, Alexander L, Cameron DB, Carroll LN, Cunnama L, Gomez GB, Levin C, Marseille E, Mustafa Diab M, Siapka M, Sinanovic E, Vassall A, Kahn JG.

Afr J AIDS Res. 2019 Dec;18(4):263-276. doi: 10.2989/16085906.2019.1680398.

PMID:
31779571
6.

The state of costing research for HIV interventions in sub-Saharan Africa.

Cameron DB, Mustafa Diab M, Carroll LN, Bollinger LA, DeCormier Plosky W, Levin C, Herzel B, Marseille E, Alexander L, Bautista-Arredondo S, Pineda-Antunez C, Cerecero-García D, Gomez GB, Dow WH, Kahn JG.

Afr J AIDS Res. 2019 Dec;18(4):277-288. doi: 10.2989/16085906.2019.1679200. Review.

PMID:
31779568
7.

Current realities versus theoretical optima: quantifying efficiency and sociospatial equity of travel time to hospitals in low-income and middle-income countries.

Wong KL, Brady OJ, Campbell OMR, Jarvis CI, Pembe A, Gomez GB, Benova L.

BMJ Glob Health. 2019 Aug 21;4(4):e001552. doi: 10.1136/bmjgh-2019-001552. eCollection 2019.

8.
9.

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model.

Sohn H, Kasaie P, Kendall E, Gomez GB, Vassall A, Pai M, Dowdy D.

BMC Med. 2019 Aug 6;17(1):155. doi: 10.1186/s12916-019-1384-8.

10.

The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.

Roberts DA, Barnabas RV, Abuna F, Lagat H, Kinuthia J, Pintye J, Bochner AF, Forsythe S, Gomez GB, Baeten JM, John-Stewart G, Levin C.

J Int AIDS Soc. 2019 Jul;22 Suppl 4:e25296. doi: 10.1002/jia2.25296.

11.

Improving the quality of modelling evidence used for tuberculosis policy evaluation.

Menzies NA, McQuaid CF, Gomez GB, Siroka A, Glaziou P, Floyd K, White RG, Houben RMGJ.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):387-395. doi: 10.5588/ijtld.18.0660.

12.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

PMID:
30904263
13.

Changes in disclosure, adherence and healthcare interactions after the introduction of immediate ART initiation: an analysis of patient experiences in Swaziland.

Molemans M, Vernooij E, Dlamini N, Shabalala FS, Khan S, van Leth F, Gomez GB, Reis R.

Trop Med Int Health. 2019 May;24(5):563-570. doi: 10.1111/tmi.13214. Epub 2019 Mar 3.

14.

The Importance of Heterogeneity to the Epidemiology of Tuberculosis.

Trauer JM, Dodd PJ, Gomes MGM, Gomez GB, Houben RMGJ, McBryde ES, Melsew YA, Menzies NA, Arinaminpathy N, Shrestha S, Dowdy DW.

Clin Infect Dis. 2019 Jun 18;69(1):159-166. doi: 10.1093/cid/ciy938.

15.

Tuberculosis.

Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P.

In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11.

16.

Empirical estimation of resource constraints for use in model-based economic evaluation: an example of TB services in South Africa.

Bozzani FM, Mudzengi D, Sumner T, Gomez GB, Hippner P, Cardenas V, Charalambous S, White R, Vassall A.

Cost Eff Resour Alloc. 2018 Jul 30;16:27. doi: 10.1186/s12962-018-0113-z. eCollection 2018.

17.

Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis.

Maljaars LP, Gill K, Smith PJ, Gray GE, Dietrich JJ, Gomez GB, Bekker LG.

South Afr J HIV Med. 2017 Sep 21;18(1):712. doi: 10.4102/sajhivmed.v18i1.712. eCollection 2017.

18.

Access to and utilisation of healthcare services by sex workers at truck-stop clinics in South Africa: A case study.

Fobosi SC, Lalla-Edward ST, Ncube S, Buthelezi F, Matthew P, Kadyakapita A, Slabbert M, Hankins CA, Venter WDF, Gomez GB.

S Afr Med J. 2017 Oct 31;107(11):994-999. doi: 10.7196/SAMJ.2017.v107i11.12379.

19.

HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.

Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, Saayman E, Moorhouse M, Venter WDF, Rees H; TAPS Demonstration Project Team.

PLoS Med. 2017 Nov 21;14(11):e1002444. doi: 10.1371/journal.pmed.1002444. eCollection 2017 Nov.

20.

Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.

Verguet S, Riumallo-Herl C, Gomez GB, Menzies NA, Houben RMGJ, Sumner T, Lalli M, White RG, Salomon JA, Cohen T, Foster N, Chatterjee S, Sweeney S, Baena IG, Lönnroth K, Weil DE, Vassall A.

Lancet Glob Health. 2017 Nov;5(11):e1123-e1132. doi: 10.1016/S2214-109X(17)30341-8.

21.

Uptake of health services among truck drivers in South Africa: analysis of routine data from nine roadside wellness centres.

Lalla-Edward ST, Ncube S, Matthew P, Hankins CA, Venter WDF, Gomez GB.

BMC Health Serv Res. 2017 Sep 13;17(1):649. doi: 10.1186/s12913-017-2595-3.

22.

Economic evaluation of TB screening programmes in migrants: need for a comprehensive framework.

Gomez GB, Rupert S, Houben RMGJ.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):953. doi: 10.5588/ijtld.17.0455. No abstract available.

PMID:
28826440
23.

Modelling approaches for tuberculosis: are they realistic? - Authors' reply.

Menzies NA, Gomez GB, Vassall A.

Lancet Glob Health. 2017 Mar;5(3):e269. doi: 10.1016/S2214-109X(17)30051-7. No abstract available.

24.

Cutting the cost of South African antiretroviral therapy using newer, safer drugs.

Venter WF, Kaiser B, Pillay Y, Conradie F, Gomez GB, Clayden P, Matsolo M, Amole C, Rutter L, Abdullah F, Abrams EJ, Casas CP, Barnhart M, Pillay A, Pozniak A, Hill A, Fairlie L, Boffito M, Moorhouse M, Chersich M, Serenata C, Quevedo J, Loots G.

S Afr Med J. 2016 Dec 21;107(1):28-30. doi: 10.7196/SAMJ.2016.v107.i1.12058.

25.

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis.

Gomez GB, Dowdy DW, Bastos ML, Zwerling A, Sweeney S, Foster N, Trajman A, Islam MA, Kapiga S, Sinanovic E, Knight GM, White RG, Wells WA, Cobelens FG, Vassall A.

BMC Infect Dis. 2016 Dec 1;16(1):726.

26.

Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.

Menzies NA, Gomez GB, Bozzani F, Chatterjee S, Foster N, Baena IG, Laurence YV, Qiang S, Siroka A, Sweeney S, Verguet S, Arinaminpathy N, Azman AS, Bendavid E, Chang ST, Cohen T, Denholm JT, Dowdy DW, Eckhoff PA, Goldhaber-Fiebert JD, Handel A, Huynh GH, Lalli M, Lin HH, Mandal S, McBryde ES, Pandey S, Salomon JA, Suen SC, Sumner T, Trauer JM, Wagner BG, Whalen CC, Wu CY, Boccia D, Chadha VK, Charalambous S, Chin DP, Churchyard G, Daniels C, Dewan P, Ditiu L, Eaton JW, Grant AD, Hippner P, Hosseini M, Mametja D, Pretorius C, Pillay Y, Rade K, Sahu S, Wang L, Houben RMGJ, Kimerling ME, White RG, Vassall A.

Lancet Glob Health. 2016 Nov;4(11):e816-e826. doi: 10.1016/S2214-109X(16)30265-0. Epub 2016 Oct 6.

27.

Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.

Houben RMGJ, Menzies NA, Sumner T, Huynh GH, Arinaminpathy N, Goldhaber-Fiebert JD, Lin HH, Wu CY, Mandal S, Pandey S, Suen SC, Bendavid E, Azman AS, Dowdy DW, Bacaër N, Rhines AS, Feldman MW, Handel A, Whalen CC, Chang ST, Wagner BG, Eckhoff PA, Trauer JM, Denholm JT, McBryde ES, Cohen T, Salomon JA, Pretorius C, Lalli M, Eaton JW, Boccia D, Hosseini M, Gomez GB, Sahu S, Daniels C, Ditiu L, Chin DP, Wang L, Chadha VK, Rade K, Dewan P, Hippner P, Charalambous S, Grant AD, Churchyard G, Pillay Y, Mametja LD, Kimerling ME, Vassall A, White RG.

Lancet Glob Health. 2016 Nov;4(11):e806-e815. doi: 10.1016/S2214-109X(16)30199-1. Epub 2016 Oct 6.

28.

Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project.

Gomez GB, Eakle R, Mbogua J, Akpomiemie G, Venter WD, Rees H.

BMJ Open. 2016 Sep 26;6(9):e011595. doi: 10.1136/bmjopen-2016-011595.

29.

Outcomes and costs of implementing a community-based intervention for hypertension in an urban slum in Kenya.

Oti SO, van de Vijver S, Gomez GB, Agyemang C, Egondi T, Kyobutungi C, Stronks K.

Bull World Health Organ. 2016 Jul 1;94(7):501-9. doi: 10.2471/BLT.15.156513. Epub 2016 Apr 26.

30.

Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.

Rosendaal NT, Hendriks ME, Verhagen MD, Bolarinwa OA, Sanya EO, Kolo PM, Adenusi P, Agbede K, van Eck D, Tan SS, Akande TM, Redekop W, Schultsz C, Gomez GB.

PLoS One. 2016 Jun 27;11(6):e0157925. doi: 10.1371/journal.pone.0157925. eCollection 2016. Erratum in: PLoS One. 2016;11(9):e0162421.

31.

Impact evaluation of a community-based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE-UP study.

van de Vijver S, Oti SO, Gomez GB, Agyemang C, Egondi T, Moll van Charante E, Brewster LM, Hankins C, Tanovic Z, Ezeh A, Kyobutungi C, Stronks K.

Glob Health Action. 2016 Mar 24;9:30922. doi: 10.3402/gha.v9.30922. eCollection 2016.

32.

Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services.

Trajman A, Bastos ML, Belo M, Calaça J, Gaspar J, Dos Santos AM, Dos Santos CM, Brito RT, Wells WA, Cobelens FG, Vassall A, Gomez GB.

BMC Health Serv Res. 2016 Jan 22;16:27. doi: 10.1186/s12913-016-1269-x.

33.

A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.

Zwerling A, Gomez GB, Pennington J, Cobelens F, Vassall A, Dowdy DW.

Int J Tuberc Lung Dis. 2016 Feb;20(2):257-60. doi: 10.5588/ijtld.15.0415.

PMID:
26792481
34.

Incorporating Demand and Supply Constraints into Economic Evaluations in Low-Income and Middle-Income Countries.

Vassall A, Mangham-Jefferies L, Gomez GB, Pitt C, Foster N.

Health Econ. 2016 Feb;25 Suppl 1:95-115. doi: 10.1002/hec.3306. Epub 2016 Jan 19.

35.

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

Knight GM, Gomez GB, Dodd PJ, Dowdy D, Zwerling A, Wells WA, Cobelens F, Vassall A, White RG.

PLoS One. 2015 Dec 30;10(12):e0145796. doi: 10.1371/journal.pone.0145796. eCollection 2015.

36.

Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.

Gomez GB, Foster N, Brals D, Nelissen HE, Bolarinwa OA, Hendriks ME, Boers AC, van Eck D, Rosendaal N, Adenusi P, Agbede K, Akande TM, Boele van Hensbroek M, Wit FW, Hankins CA, Schultsz C.

PLoS One. 2015 Sep 28;10(9):e0139048. doi: 10.1371/journal.pone.0139048. eCollection 2015.

37.

Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.

Lukoye D, Ssengooba W, Musisi K, Kasule GW, Cobelens FG, Joloba M, Gomez GB.

BMC Public Health. 2015 Mar 25;15:291. doi: 10.1186/s12889-015-1614-8. Review.

38.

Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.

Günther G, Gomez GB, Lange C, Rupert S, van Leth F; TBNET.

Eur Respir J. 2015 Apr;45(4):1081-8. doi: 10.1183/09031936.00124614. Epub 2014 Nov 13.

39.

Risk pathways for gonorrhea acquisition in sex workers: can we distinguish confounding from an exposure effect using a priori hypotheses?

Gomez GB, Ward H, Garnett GP.

J Infect Dis. 2014 Dec 1;210 Suppl 2:S579-85. doi: 10.1093/infdis/jiu484. Review.

40.

Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria.

Hendriks ME, Bolarinwa OA, Nelissen HE, Boers AC, Gomez GB, Tan SS, Redekop W, Adenusi P, Lange JM, Agbede K, Akande TM, Schultsz C.

J Hypertens. 2015 Feb;33(2):376-684. doi: 10.1097/HJH.0000000000000402.

PMID:
25380164
41.

Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.

Dowdy DW, Houben R, Cohen T, Pai M, Cobelens F, Vassall A, Menzies NA, Gomez GB, Langley I, Squire SB, White R; TB MAC meeting participants.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1012-8. doi: 10.5588/ijtld.13.0851.

42.

Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis.

Fofana MO, Knight GM, Gomez GB, White RG, Dowdy DW.

PLoS One. 2014 May 9;9(5):e96389. doi: 10.1371/journal.pone.0096389. eCollection 2014.

43.

Step-by-step guideline for disease-specific costing studies in low- and middle-income countries: a mixed methodology.

Hendriks ME, Kundu P, Boers AC, Bolarinwa OA, Te Pas MJ, Akande TM, Agbede K, Gomez GB, Redekop WK, Schultsz C, Swan Tan S.

Glob Health Action. 2014 Mar 28;7:23573. doi: 10.3402/gha.v7.23573. eCollection 2014.

44.

The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model.

Kahn JG, Jiwani A, Gomez GB, Hawkes SJ, Chesson HW, Broutet N, Kamb ML, Newman LM.

PLoS One. 2014 Jan 29;9(1):e87510. doi: 10.1371/journal.pone.0087510. eCollection 2014.

45.

A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trial.

Oti SO, van de Vijver SJ, Kyobutungi C, Gomez GB, Agyemang C, Moll van Charante EP, Brewster LM, Hendriks ME, Schultsz C, Ettarh R, Ezeh A, Lange J.

Trials. 2013 Dec 1;14:409. doi: 10.1186/1745-6215-14-409.

46.

Introducing a model of cardiovascular prevention in Nairobi's slums by integrating a public health and private-sector approach: the SCALE-UP study.

van de Vijver S, Oti S, Tervaert TC, Hankins C, Kyobutungi C, Gomez GB, Brewster L, Agyemang C, Lange J.

Glob Health Action. 2013 Oct 21;6:22510. doi: 10.3402/gha.v6i0.22510.

47.

Do support groups members disclose less to their partners? The dynamics of HIV disclosure in four African countries.

Hardon A, Gomez GB, Vernooij E, Desclaux A, Wanyenze RK, Ky-Zerbo O, Kageha E, Namakhoma I, Kinsman J, Spronk C, Meij E, Neuman M, Obermeyer CM.

BMC Public Health. 2013 Jun 17;13:589. doi: 10.1186/1471-2458-13-589.

49.

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.

Gomez GB, Borquez A, Case KK, Wheelock A, Vassall A, Hankins C.

PLoS Med. 2013;10(3):e1001401. doi: 10.1371/journal.pmed.1001401. Epub 2013 Mar 12. Review.

50.

Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis.

Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ.

Bull World Health Organ. 2013 Mar 1;91(3):217-26. doi: 10.2471/BLT.12.107623. Epub 2013 Jan 17. Review.

Supplemental Content

Loading ...
Support Center